| Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108) |
|---|
| 04/11/2007 | CN1944419A Process for synthesizing bibenzene tetracarboxylic dianhydride |
| 04/11/2007 | CN1309715C N-acylaminoacetonitrile derivatives and their use for controlling parasites |
| 04/11/2007 | CN1309714C Process for producing ethers |
| 04/11/2007 | CN1309709C C2 phenyl-substituted cyclic keto-enols used as pesticides and herbicides |
| 04/11/2007 | CN1309470C Hydrogenation catalyst, preparation thereof, and method for the preparation of gamma-butyrolactone from maleic anhydride using the catalyst |
| 04/10/2007 | US7202380 Production method of pyromellitic acid and pyromellitic anhydride |
| 04/10/2007 | US7202274 Cyclic hemiacetal derivative and use thereof |
| 04/10/2007 | US7202253 Cycloalkyl inhibitors of potassium channel function |
| 04/10/2007 | US7202085 Acylated Homoserine Lactone (AHL) compounds and AHL receptors derived from bacterial quorum sensing systems; inducible or repressible promotors regulate gene expression in plants and plant cells |
| 04/10/2007 | CA2389379C Method for the preparation of 5-carboxyphthalide |
| 04/10/2007 | CA2337991C Benzocycloheptenes, process for their production, pharmaceutical preparations that contain the latter as well as their use for the production of pharmaceutical agents |
| 04/10/2007 | CA2212895C Benzylpiperidines and piperazines as muscarinic antagonists |
| 04/05/2007 | WO2007037213A1 Cyano-containing polycyclic esters having lactone skeletons |
| 04/05/2007 | WO2007037187A1 Sulfonamide derivative having pgd2 receptor antagonistic activity |
| 04/05/2007 | WO2007002172A3 Hiv-1 protease inhibitors |
| 04/05/2007 | WO2006076452A3 An exo-selective synthesis of himbacine analogs |
| 04/05/2007 | US20070078273 Process for preparing 5-methyl-2-furfural |
| 04/05/2007 | US20070078178 ethyl 3-[2-(4-chlorophenyl)-2-oxoethoxy]benzo[b]thiophene-2-carboxylate; non-insulin dependent diabetes, obesity, hypotensive agent; athrosclerosis, retinopathy |
| 04/05/2007 | US20070078173 Alpha- and beta-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 04/05/2007 | US20070078156 Derivatives of n-(1h-indazolyl)-and n-(1h-indolyl)-urea as well as related compounds as modulators of the vanilloid-1 receptor (vr1) for treatment of pain |
| 04/05/2007 | US20070078139 Phosphodiesterase 4 inhibitors |
| 04/05/2007 | US20070078130 Dual alanyl aminopeptidase and dipeptidyl peptidase iv inhibitors for functionally influencing different cells and for treating immunological inflammatory, neuronal and other diseases |
| 04/05/2007 | CA2621310A1 Sulfonamide derivative having pgd2 receptor antagonistic activity |
| 04/04/2007 | EP1770089A1 Pyranodibenzofuran derivatives with antifungal and antibacterial activity |
| 04/04/2007 | EP1770088A1 Process for preparing 5-methyl-2-furfural |
| 04/04/2007 | EP1770083A1 Inorganic ion receptor-active compounds |
| 04/04/2007 | EP1768971A1 Novel o-aminophenol derivatives and colorants containing said compounds |
| 04/04/2007 | EP1768969A2 Crystalline mycophenolate sodium |
| 04/04/2007 | EP1768968A1 2-((hetero) aryl)-benzoxazole compounds and derivatives, compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding |
| 04/04/2007 | EP1768954A2 2-methylpropanamides and their use as pharmaceuticals |
| 04/04/2007 | EP1227721B1 Novel substituted succinic acid metallo-beta-lactamase inhibitors and their use in treating bacterial infections |
| 04/04/2007 | CN1942551A New organic luminescent element |
| 04/04/2007 | CN1942461A Dibenzofuran-, dibenzothiophene- and fluorene derivatives |
| 04/04/2007 | CN1942457A 1,3,5-substituted phenyl derivative compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease |
| 04/04/2007 | CN1942434A Indene derivatives and process for the preparation thereof |
| 04/04/2007 | CN1942428A CETP inhibitors |
| 04/04/2007 | CN1942419A Method for establishing CC bonds between electrophilic substrates and pi - nucleophiles in neutral to alkaline aqueous or alcoholic solvents without using a lewis or bronsted acid |
| 04/04/2007 | CN1939914A Process for preparing 5-methyl-2-furfural |
| 04/04/2007 | CN1939896A Aromatic compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 04/04/2007 | CN1308330C Single pot conversion of artemisinin into arteether |
| 04/04/2007 | CN1308321C Jujube kernel saponin derivative and its preparation method and use |
| 04/04/2007 | CN1308320C Substituted naphthyl benzofuran derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1) |
| 04/04/2007 | CN1308319C Process for synthesis of HIV protease inhibitors |
| 04/04/2007 | CN1308310C Nitrogenous aromatic ring compounds |
| 04/04/2007 | CN1308302C Taxol enhancer compounds |
| 04/04/2007 | CN1308080C Porous catalyst for the hydrogenation of maleic anhydride to tetrahydrofuran |
| 04/03/2007 | US7199254 Liquid phase synthesis of methylene lactones using novel catalyst |
| 04/03/2007 | US7199150 Amino alcohol compounds |
| 04/03/2007 | US7199148 Such as (1-Benzyl-2-hydroxy-3-{isobutyl-[2-oxo-3-(1H-pyrrol-2-ylmethylene)-2,3-dihydro-1H-indole-5-sulfonyl]-amino}-propyl)-carbamic acid hexahydro-furo[2,3-b]furan-3-yl ester; multi-drug resistant HIV infections |
| 04/03/2007 | US7199140 (bis(Phenoxy or phenylsulfonamido)phenylethyl)pyridyl carboxylic acids, esters or amides; antidiabetic agents; obesity; glucokinase agonists |
| 04/03/2007 | CA2163174C Hindered aromatic ester compounds useful as anti-viral agents |
| 03/29/2007 | WO2007035066A1 The method of making optically active 3-acyloxy-gamma-butyrolactone and optically active 3-hydroxy-gamma-butyrolactone by enzymatic method |
| 03/29/2007 | WO2007034558A1 Process for producing anhydrous 3-hydroxyphthalic acid |
| 03/29/2007 | WO2007010514A3 Compounds and their salts specific to the ppar receptors and the egf receptors and their use in the medical field |
| 03/29/2007 | WO2007010085A3 New pharmaceutical compounds |
| 03/29/2007 | WO2007010085A2 New pharmaceutical compounds |
| 03/29/2007 | WO2007002635A3 C-linked cyclic antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
| 03/29/2007 | WO2005112640A3 Compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases |
| 03/29/2007 | US20070073067 Supercritical fluid phase synthesis of methylene lactones using catalysts derived from hydrotalcites |
| 03/29/2007 | US20070072935 Catalytic antioxidants and methods of use |
| 03/29/2007 | US20070072909 Methods for making 4-tetrazolyl-4-phenylpiperidine compounds |
| 03/29/2007 | DE102005044156A1 Substituierte Acetophenonderivate Substituted acetophenone |
| 03/29/2007 | DE102005017326A1 Tetrahydronaphthalinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer Tetrahydronaphthalene derivatives, processes for their preparation and their use as anti-inflammatories |
| 03/28/2007 | EP1767531A1 Medicinal compositions containing 6-hydroxybenzbromarone or salts thereof |
| 03/28/2007 | EP1767529A1 Pyridazine compound and use thereof |
| 03/28/2007 | EP1765803A1 Quaternary salt ccr2 antagonists |
| 03/28/2007 | CN1938316A Methods for the preparation of (3r,3as,6ar) hexahydro-furo[2,3-b]furan-3-ol |
| 03/28/2007 | CN1938258A Ester derivatives of rhein and their therapeutic use |
| 03/28/2007 | CN1935801A Benzofuranone-like stabilizer and its use |
| 03/28/2007 | CN1935800A Compound with anti cerebralischemia, myo cardialischemia and memory-improving functions, and its preparing method and use |
| 03/28/2007 | CN1935799A Medicine intermediate tanshinone IIA extracting process |
| 03/28/2007 | CN1935798A Method for preparing and rographalide |
| 03/28/2007 | CN1935797A Novel bichalcophenes and their prodrugs as antiprotozoal agents |
| 03/28/2007 | CN1935374A Zirconium-base loaded vanadium-phosphor oxide catalyst, and its preparing and use |
| 03/28/2007 | CN1307170C Method for separating effective ingredient lagehead atractylodes lactone ó¾ from lagehead atractylodes naphtha |
| 03/28/2007 | CN1307169C Conversion of tetrahydroxybutane to tetrahydrofuran |
| 03/28/2007 | CN1307156C Polyarylcarboxamides useful as lipid lowering agents |
| 03/27/2007 | USRE39530 Dimethyl-{[2-(2-methylbenzyloxy)cyclohexyl]phenylmethyl}-amine; analgesically active, treatment of pain, local anaesthetic, antiarrhythmic, antiemetic cardiovascular diseases, urinary incontinence, diarrhea, pruritus, alcohol, drug or medicament dependency, inflammations |
| 03/27/2007 | US7196208 Chemical intermediate; carbonylation using carbon monoxide using palladium catalyst |
| 03/27/2007 | US7196198 For therapy and prophylaxis of bone diseases, cancer, systemic granuloma, immunological diseases, allergy, atopy, asthma, gumboil, gingivitis, periodontitis, neurocyte death, Alzheimer's diseases, lungs injury, pulmopathy, acute hepatitis |
| 03/27/2007 | US7196108 Bicyclic heterocycles for the treatment of diabetes and other diseases |
| 03/27/2007 | US7196102 Osteoporosis, bone disorders, or diseases associated with excessive secretion of PTH, such as hyperparathyroidism; reduce or inhibit parathyroid hormone (PTH) secretion |
| 03/27/2007 | US7196099 Compounds and compositions as cathepsin inhibitors |
| 03/27/2007 | US7196089 Administering to a patient a furan ring containing compound as prostaglandin E4 receptor antagonist to treat various diseases, such as migraines and headache |
| 03/27/2007 | CA2193460C 3-amino-2-mercaptobenzoic acid derivatives and processes for their preparation |
| 03/22/2007 | WO2007032362A1 Substituted cycloalkene derivative |
| 03/22/2007 | WO2007031791A1 Biphenyl derivatives and their use in treating hepatitis c |
| 03/22/2007 | WO2006105127A3 Hydroxysteroid dehydrogenase inhibitors |
| 03/22/2007 | US20070066836 Method for producing phthalic anhydride |
| 03/22/2007 | US20070066681 Pharmaceutical composition for treating fatty liver or hepatic disease |
| 03/22/2007 | US20070066680 Benzofurans and benzothiophenes |
| 03/22/2007 | US20070066664 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses, materials for their synthesis |
| 03/22/2007 | US20070066658 N-{4-[4-(2-Benzylamino-ethyl)-phenoxy]-phenyl}-acetamide; eating disorders; antidiabetic, -arthritic, -epileptic, anxiolytic -lipedemic agents; anxiolytic, hypoglycemic and hypotensive agents; sexual disorders, antidepressants, hypertriglycemia, hyperlipoproteinemia, drug abuse; behavior disorders |
| 03/22/2007 | US20070066623 Entry inhibitors of the hiv virus |
| 03/22/2007 | US20070066600 Compounds |
| 03/22/2007 | US20070066599 New compounds |
| 03/22/2007 | US20070066598 Compounds |
| 03/22/2007 | US20070066575 Methods and compositions for mitigating pain |
| 03/22/2007 | US20070063190 Aromatic compound |
| 03/22/2007 | CA2621364A1 Biphenyl derivatives and their use in treating hepatitis c |